Quantitation of human immunodeficiency virus type 1 infection kinetics.
about
A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell lineExtensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients.Cell-to-cell transmission of retroviruses: Innate immunity and interferon-induced restriction factorsHeterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication.Molecular Studies of HTLV-1 Replication: An UpdateThe immunological synapse: the gateway to the HIV reservoirCatching HIV 'in the act' with 3D electron microscopyRab27a controls HIV-1 assembly by regulating plasma membrane levels of phosphatidylinositol 4,5-bisphosphateNucleocapsid promotes localization of HIV-1 gag to uropods that participate in virological synapses between T cellsCell-to-cell contact facilitates HIV transmission from lymphocytes to astrocytes via CXCR4.Assembly of the murine leukemia virus is directed towards sites of cell-cell contactHIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIVNMR Structure in a Membrane Environment Reveals Putative Amyloidogenic Regions of the SEVI Precursor Peptide PAP 248−286HIV Cell-to-Cell Spread Results in Earlier Onset of Viral Gene Expression by Multiple Infections per CellMembrane dynamics associated with viral infectionDissecting How CD4 T Cells Are Lost During HIV InfectionMacrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humansThe phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cellsMulti-scale modeling of HIV infection in vitro and APOBEC3G-based anti-retroviral therapyModelling HIV and MTB co-infection including combined treatment strategiesThe microvesicle component of HIV-1 inocula modulates dendritic cell infection and maturation and enhances adhesion to and activation of T lymphocytesDecreased phenotypic susceptibility to etravirine in patients with predicted genotypic sensitivityConditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function.Human immunodeficiency virus type 1 and influenza virus exit via different membrane microdomains.Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses.Human immunodeficiency virus type 1 envelope gp120 induces a stop signal and virological synapse formation in noninfected CD4+ T cells.Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission.Quantitative 3D video microscopy of HIV transfer across T cell virological synapsesOn the steps of cell-to-cell HIV transmission between CD4 T cellsHuman immunodeficiency virus type 1 envelope gp120-induced partial T-cell receptor signaling creates an F-actin-depleted zone in the virological synapseVirological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibitionTetherin restricts direct cell-to-cell infection of HIV-1.Coxsackievirus B3-induced cellular protrusions: structural characteristics and functional competenceMultiploid inheritance of HIV-1 during cell-to-cell infection.Macrophage internal HIV-1 is protected from neutralizing antibodies.Neutralization resistance of virological synapse-mediated HIV-1 Infection is regulated by the gp41 cytoplasmic tailAntiretroviral agents effectively block HIV replication after cell-to-cell transfer.Synaptic transmission and the susceptibility of HIV infection to anti-viral drugsThree-dimensional imaging of HIV-1 virological synapses reveals membrane architectures involved in virus transmission.A comparison of elasticities of viral levels to specific immune response mechanisms in human immunodeficiency virus infection.
P2860
Q21245053-73AFB07C-2EF8-47CF-86C4-2EF696FA3772Q22242225-9774BE3E-0833-4E30-8E50-C90E0DC799AFQ24604018-D1BF1FFF-0C6B-4E4C-AD95-533EFC7E2711Q24652351-43667556-54A5-4EDB-A87D-64A74ACC5E0EQ26772930-13B413EE-C52E-447E-BCD9-7CFCB9438464Q27002959-E9550E45-F7A3-42AC-936B-D4E44D1BE5CEQ27026806-CF3944BE-05CE-466B-983F-7B63C8B68397Q27310788-ACA41823-56A3-463F-9F87-D10EBEA19FFEQ27312753-B8C81D49-FCD8-4CBD-BAC4-3E8C5C50867DQ27313520-C715F521-191E-4D6A-8CDD-03C6EFC97358Q27329731-644F685B-A19E-4F2D-B3D7-42FD323CFD6DQ27497560-18F56C82-D093-42DE-A6BA-674E2171E11AQ27658538-644CB002-A2D0-4342-9E69-49FA69F013D4Q27681313-ABF1F4D5-E673-45B7-A287-BB2414CD2553Q28069980-54A469DB-4283-472B-B9A0-324815D3C1C4Q28274045-65DC1E7E-E296-4D6B-9D81-DED507022CD8Q28345408-B7647CA4-1384-4551-AEBB-64D80113290CQ28368938-650AA57B-3D71-4B1F-BB49-94ADE556264AQ28480578-E1801787-FC0E-432C-B09E-0AA45253CD21Q28485357-463019F3-7A3A-4F80-9B53-E935DA6B4463Q28534504-C674C8F4-9274-4101-9046-793DAD8351AEQ28540368-9E0369AE-3899-4231-9AC5-7831379C465AQ30424775-53865834-07E9-4A82-B618-9E18C059429DQ30480954-64840CF6-7564-464C-88E2-5A4B139C4147Q30480959-6245C7AF-0ED4-40A2-9609-808B7254B783Q30483680-87F6F828-0EFF-4AB5-A029-C506E99666ECQ30485520-3E3FC312-8815-47C5-B0FE-44D383FA86D1Q30490761-88AB8C73-031F-4947-8AC0-BE620FE7948CQ30491261-C492B041-291A-461E-ABC9-BE9144425123Q30491420-0EEA064B-DD9B-4942-AF8D-60F74F0C828AQ30493649-1DD0D448-8D66-4B1B-9909-DA3B30D43BC1Q30497822-C475E63A-1619-4207-B541-BA4BC48ADF50Q30501771-19B62E87-E212-4634-85A9-5A947A9C15D5Q30501773-F244474C-C3E3-447C-9F6D-665062F94BEAQ30510067-EDBCF7F1-2FCD-4EE6-B86B-83221552BF48Q30524110-BD6C3ABC-F724-4816-A3DC-821E40ACA2A9Q30524224-EF78A1D1-7527-44DB-AC7F-3C268FD95CC5Q30541026-96493779-239D-4C56-A108-1534AF27ABDFQ30588474-D439BE5A-C112-48FE-8624-1DF47A40C148Q30596957-4648C641-A5DF-44BD-9B27-E4B3BCD5D03A
P2860
Quantitation of human immunodeficiency virus type 1 infection kinetics.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Quantitation of human immunodeficiency virus type 1 infection kinetics.
@ast
Quantitation of human immunodeficiency virus type 1 infection kinetics.
@en
type
label
Quantitation of human immunodeficiency virus type 1 infection kinetics.
@ast
Quantitation of human immunodeficiency virus type 1 infection kinetics.
@en
prefLabel
Quantitation of human immunodeficiency virus type 1 infection kinetics.
@ast
Quantitation of human immunodeficiency virus type 1 infection kinetics.
@en
P2093
P2860
P1433
P1476
Quantitation of human immunodeficiency virus type 1 infection kinetics.
@en
P2093
P2860
P304
P407
P577
1993-04-01T00:00:00Z